Screen · Berkshire Criteria

Buffett Quality Screen

Buffett's "wonderful business" criteria, quantified into six dimensions: earnings record (20), ROE quality (25 — Fortune's double standard), low leverage (15), pricing power (15), business stability (15) and capital efficiency (10), for a 0–100 total. The entry gate is the first of Berkshire's acquisition criteria — at least $50M average pre-tax earnings over the last three fiscal years (banks and insurers excluded, as leverage is their business model; investment trusts and closed-end funds excluded, as they are portfolios rather than operating companies). Recomputed periodically from each company's last ten fiscal years; cross-listings merged by canonical ticker. Hover the score for the six-dimension breakdown; companies we cover link to their report. score tier "優良"、market "China A-shares"、market cap "Small <$2B"で絞り込み：23 match(絞り込みを解除)。

#	銘柄	Mkt Cap	Score▼	10Y ROE	Profit Streak	Net Debt/Eq	Gross Margin	レポート	FY
1	Lao Feng Xiang Co Ltd B 900905 · 上海	$1.6B	76/100 優良	18.6%low 13.3%	10 yr+	—	8%	—	FY2025
2	Guangzhou Restaurants Group Co 603043 · 上海	$1.1B	76/100 優良	17.7%low 11.5%	10 yr+	0.0×	48%	—	FY2025
3	Shanghai Shuixing Home Textile Co Ltd Class A 603365 · 上海	$661M	76/100 優良	13.6%low 10.1%	10 yr+	Net cash	38%	—	FY2025
4	Beijing Caishikou Department Store Co Ltd 605599 · 上海	$1.8B	74/100 優良	17.6%low 11.3%	9 yr	Net cash	11%	—	FY2025
5	Chongqing Chuanyi Automation Co Ltd 603100 · 上海	$1.4B	74/100 優良	14.0%low 6.9%	10 yr+	Net cash	32%	—	FY2025
6	Yapp Automotive Systems Co Ltd 603013 · 上海	$1.2B	74/100 優良	13.6%low 11.0%	10 yr+	Net cash	15%	—	FY2025
7	Chengdu Gas Group Co Ltd 603053 · 上海	$1.1B	74/100 優良	15.1%low 9.9%	10 yr+	Net cash	20%	—	FY2025
8	Jingjin Environmental Protection Co Ltd 603279 · 上海	$1.1B	74/100 優良	15.9%low 9.7%	10 yr+	Net cash	30%	—	FY2025
9	Jiangsu Liba Enterprise Joint-Stock Co Ltd 603519 · 上海	$554M	74/100 優良	19.1%low 10.5%	10 yr+	Net cash	15%	—	FY2025
10	China National Electric Apparatus R 688128 · 上海	$1.3B	73/100 優良	16.1%low 11.3%	10 yr+	Net cash	37%	—	FY2025
11	ZhuZhou QianJin Pharmaceutical Co Ltd 600479 · 上海	$679M	73/100 優良	11.9%low 8.6%	10 yr+	Net cash	51%	—	FY2025
12	Tibet Rhodiola Pharmaceutical Holding Co 600211 · 上海	$1.7B	72/100 優良	17.6%low 7.9%	10 yr+	Net cash	86%	—	FY2025
13	Mayinglong Pharmaceutical Group Co Ltd 600993 · 上海	$1.5B	72/100 優良	13.1%low 7.8%	10 yr+	Net cash	43%	—	FY2025
14	Beijing Winsunny Pharmaceutical CO.LTD 601089 · 上海	$1.2B	72/100 優良	17.7%low 12.4%	6 yr	—	68%	—	FY2025
15	Suzhou Secote Precision Electronic Co Ltd Class A 603283 · 上海	$1.9B	71/100 優良	16.7%low 12.1%	10 yr+	0.1×	44%	—	FY2025
16	Ficont Industry (Beijing) Co. Ltd. 605305 · 上海	$1.2B	71/100 優良	14.0%low 7.2%	10 yr+	Net cash	50%	—	FY2025
17	Keli Sensing Technology Ningbo Co Ltd 603662 · 上海	$2.0B	70/100 優良	11.4%low 8.8%	10 yr+	Net cash	41%	—	FY2025
18	Southern Publishing&Media Co 601900 · 上海	$1.5B	70/100 優良	12.5%low 9.8%	10 yr+	Net cash	31%	—	FY2025
19	Hangzhou Honghua Digital Technology Stock Company LTD 688789 · 上海	$1.2B	69/100 優良	18.3%low 11.4%	10 yr+	Net cash	48%	—	FY2025
20	Shanghai Bloom Technology Inc 603325 · 上海	$603M	69/100 優良	21.4%low 7.0%	8 yr	Net cash	33%	—	FY2025
21	Chongqing Department Store Co Ltd 600729 · 上海	$1.3B	67/100 優良	15.0%low 9.0%	10 yr+	0.1×	19%	—	FY2025
22	Zhejiang Huangma Technology Co Ltd 603181 · 上海	$1.1B	67/100 優良	14.8%low 11.5%	10 yr+	Net cash	22%	—	FY2025
23	Quechen Silicon Chemical Co. Ltd. 605183 · 上海	$859M	65/100 優良	14.5%low 8.1%	10 yr+	Net cash	35%	—	FY2025

Data and methodology: the six dimensions quantify Berkshire's published acquisition criteria and Buffett's shareholder letters (1981/1987/1991/2007 among others). Qualitative tests in the originals (e.g. "simple, understandable business", "management in place") are out of scope, and price ("available at a fair price") is covered by each report's valuation range instead. Financials come from company annual reports (via EODHD); ratios are computed in reporting currency, the USD gate via static FX. "‡" marks companies whose equity is persistently negative or tiny (ROE falls back to ROCE); "†" marks missing gross profit (operating margin used). Investment trusts and closed-end funds are excluded on two tests — name and financial shape (operating margins beyond what an operating company can achieve); REITs and operating asset managers are unaffected. This is a quantitative first pass, not investment advice. When citing this data, please credit Zen Horizon (zh.app). See our methodology for the scoring process.